Inventor · disambiguated record
Horacio G. Nastri
Also filed as: NASTRI HORACIO G · NASTRI HORACIO GABRIEL
13 granted patents·11 pending applications·137 citations·filing 2001–2024
91Inventor score
Top patents by PatentIndex Score
24 records- 0196US9624298B2Anti-PD-L1 antibodies and uses thereofMERCK PATENT GMBH·Filed 2012·Granted Apr 18, 2017·76 cites·35 claims
- 0294US10487147B2Anti-PD-L1 antibodies and uses thereofMERCK PATENT GMBH·Filed 2017·Granted Nov 26, 2019·19 cites·25 claims
- 0390US9683028B2Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel librariesDYAX CORP·Filed 2014·Granted Jun 20, 2017·5 cites·20 claims
- 0490US8901045B2Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel librariesLADNER ROBERT C·Filed 2012·Granted Dec 2, 2014·8 cites·14 claims
- 0587US11993654B2PD-1 binding domainsMERUS NV·Filed 2022·Granted May 28, 2024·1 cites·20 claims
- 0687US10829541B2Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel librariesDYAX CORP·Filed 2017·Granted Nov 10, 2020·2 cites·17 claims
- 0785US11884724B2Anti-PD-L1 antibodies and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Jan 30, 2024·1 cites·14 claims
- 0885US10759856B2Anti-PD-L1 antibodies and uses thereofMERCK PATENT GMBH·Filed 2017·Granted Sep 1, 2020·2 cites·21 claims
- 0984US8288322B2Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel librariesLADNER ROBERT C·Filed 2001·Granted Oct 16, 2012·18 cites·18 claims
- 1083US9382535B2Methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteinsLADNER ROBERT C·Filed 2006·Granted Jul 5, 2016·5 cites·27 claims
- 1176US2024425594A1Novel pd-1 binding domainsMERUS NV·Filed 2024·Application pending·0 cites
- 1276US2024425595A1Novel pd-1 binding domainsMERUS NV·Filed 2024·Application pending·0 cites
- 1375US2025059293A1Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapyINCYTE CORP·Filed 2024·Application pending·0 cites
- 1473US2024352143A1Anti-cd73 antibodies and uses thereofINCYTE CORP·Filed 2024·Application pending·0 cites
- 1573US2021087256A1Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel librariesDYAX CORP·Filed 2020·Application pending·0 cites
- 1665US12018089B2Anti-CD73 antibodies and uses thereofINCYTE CORP·Filed 2020·Granted Jun 25, 2024·0 cites·27 claims
- 1762US12060433B2CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapyINCYTE CORP·Filed 2020·Granted Aug 13, 2024·0 cites·39 claims
- 1862US2023250190A1Binding domains against cancer-associated muc1MERUS NV·Filed 2022·Application pending·0 cites
- 1961US2021205311A1Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 InhibitorsINCYTE CORP·Filed 2020·Application pending·0 cites
- 2058US2022233529A1Combination therapy comprising a2a/a2b inhibitors, pd-1/pd-l1 inhibitors, and anti-cd73 antibodiesINCYTE CORP·Filed 2021·Application pending·0 cites
- 2158US2023272055A1Anti-mutant calreticulin (calr) antibodies and uses thereofINCYTE CORP·Filed 2022·Application pending·0 cites
- 2256US2022363761A1Multispecific binding moieties comprising novel pd-1 binding domainsMERUS NV·Filed 2022·Application pending·0 cites
- 2351US2004029113A1Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteinsFiled 2001·Application pending·0 cites
- 2446US9534054B2Monoclonal antibody directed against CXCR5ARES TRADING SA·Filed 2014·Granted Jan 3, 2017·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →